In addition, the PNPLA3 genotype has been elucidated as a modifier of NAFLD-associated metabolic systemic diseases such as carotid atherosclerosis [35] and chronic kidney disease [36]. The gene discussed is PNPLA3; the disease is carotid atherosclerosis.